GlassScriptPhysician profile
Assia Bromberg
NPI 1629047261
$4,840.44
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,374 · 2020: $923 · 2021: $1,628 · 2022: $916.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,304.46 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $1,161.10 | 2019-2022 | |
| Abbvie INC. | $686.35 | 2019-2022 | |
| Allergan, INC. | $284.81 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $258.08 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $241.23 | 2019-2021 | |
| Mylan Specialty L.P. | $236.22 | 2019-2022 | |
| Lilly USA, LLC | $155.93 | 2019-2022 | |
| Novo Nordisk INC | $142.70 | 2019-2022 | |
| Boston Scientific Corporation | $117.44 | 2021 | |
| Electromed, INC. | $52.94 | 2021-2022 | |
| Amarin Pharma, INC. | $28.85 | 2020-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $28.49 | 2019 | |
| Grifols USA, LLC | $27.06 | 2021 | |
| Genentech USA, INC. | $16.64 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Radius Health, INC. | $14.96 | 2019 | |
| Pfizer INC. | $14.93 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $14.64 | 2019 | |
| Sanofi Pasteur INC. | $14.23 | 2019 | |
| Gilead Sciences, INC. | $13.51 | 2022 | |
| Amgen INC. | $13.00 | 2020 | |
| Dynavax Technologies Corporation | $12.87 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Assia Bromberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.